Restricted accessResearch articleFirst published online 2023-10
α-Ketoglutarate Attenuates Hyperlipidemia-Induced Endothelial Damage by Activating the Erk-Nrf2 Signaling Pathway to Inhibit Oxidative Stress and Mitochondrial Dysfunction
α-Ketoglutarate (AKG) is an intermediate of the tricarboxylic acid cycle and a key hub linking amino acid metabolism and glucose oxidation. Previous studies have shown that AKG improved cardiovascular diseases such as myocardial infarction and myocardial hypertrophy through antioxidant and lipid-lowering characteristics. However, its protective effect and mechanism on endothelial injury caused by hyperlipidemia have not been elucidated yet. In this study, we tested whether AKG possesses protective effects on hyperlipidemia-induced endothelial injury and studied the mechanism.
Results:
AKG administration both in vivo, and in vitro significantly suppressed the hyperlipidemia-induced endothelial damage, regulated ET-1 and nitric oxide levels, and reduced the inflammatory factor interleukin-6 and matrix metallopeptidase-1 by inhibiting oxidative stress and mitochondrial dysfunction. The protective effects were achieved by the mechanism of activating the Nrf2 phase II system through the ERK signaling pathway.
Innovation:
These results reveal the role of the AKG-ERK-Nrf2 signaling pathway in the prevention of hyperlipidemia-induced endothelial damage, and suggest that AKG, as a mitochondria-targeting nutrient, is a potential drug for the treatment of endothelial damage in hyperlipidemia.
Conclusion:
AKG ameliorated the hyperlipidemia-induced endothelial damage and inflammatory response by inhibiting oxidative stress and mitochondrial dysfunction. Antioxid. Redox Signal. 39, 777–793.
Color images are available online.
Get full access to this article
View all access options for this article.
References
1.
Abdel MalikR, ZippelN, FrömelT, et al.AMP-activated protein kinase α2 in neutrophils regulates vascular repair via hypoxia-inducible factor-1α and a network of proteins affecting metabolism and apoptosis. Circ Res, 2017; 120:99–109.
2.
AnD, ZengQ, ZhangP, et al.Alpha-ketoglutarate ameliorates pressure overload-induced chronic cardiac dysfunction in mice. Redox Biol, 2021; 46:102088.
3.
Asadi ShahmirzadiA, EdgarD, LiaoCY, et al.Alpha-ketoglutarate, an endogenous metabolite, extends lifespan and compresses morbidity in aging mice. Cell Metab, 2020; 32:447–456.e6.
4.
BaiB, YangY, WangQ, et al.NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis, 2020; 11:776.
5.
BairdL, YamamotoM. The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol, 2020; 40:e00099-20.
6.
BatumalaieK, AminMA, MuruganDD, et al.Withaferin A protects against palmitic acid-induced endothelial insulin resistance and dysfunction through suppression of oxidative stress and inflammation. Sci Rep, 2016; 6:27236.
7.
CaoK, WangK, YangM, et al.Punicalagin improves hepatic lipid metabolism via modulation of oxidative stress and mitochondrial biogenesis in hyperlipidemic mice. Food Funct, 2020; 11:9624–9633.
8.
ChandelS, SathisA, DharM, et al.Hyperinsulinemia promotes endothelial inflammation via increased expression and release of Angiopoietin-2. Atherosclerosis, 2020; 307:1–10.
9.
ChengD, LiuJ. Research progress of α-ketoglutarate in cardiovascular diseases. Chin Bull Life Sci, 2022; 34:554–564.
10.
CheungKL, LeeJH, ShuL, et al.The Ras GTPase-activating-like protein IQGAP1 mediates Nrf2 protein activation via the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)-ERK pathway. J Biol Chem, 2013; 288:22378–22386.
11.
ChłopickiS, GryglewskiRJ. Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium. Pharmacol Rep, 2005; 57(Suppl):86–96.
12.
Di LisaF, KaludercicN, CarpiA, et al.Mitochondria and vascular pathology. Pharmacol Rep, 2009; 61:123–130.
FilipR, PierzynowskiSG. The absorption, tissue distribution and excretion of enteraly administered alpha-ketoglutarate in rats. J Anim Physiol Anim Nutr (Berl), 2008; 92:182–189.
15.
FiorelliS, PorroB, CosentinoN, et al.Activation of Nrf2/HO-1 pathway and human atherosclerotic plaque vulnerability:an in vitro and in vivo study. Cells, 2019; 8:356.
16.
FreigangS, AmpenbergerF, SpohnG, et al.Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. Eur J Immunol, 2011; 41:2040–2051.
17.
GansemerER, MccommisKS, MartinoM, et al.NADPH and glutathione redox link TCA cycle activity to endoplasmic reticulum homeostasis. iScience, 2020; 23:101116.
18.
GuoC, WangJ, JingL, et al.Mitochondrial dysfunction, perturbations of mitochondrial dynamics and biogenesis involved in endothelial injury induced by silica nanoparticles. Environ Pollut, 2018; 236:926–936.
19.
IncalzaMA, D'oriaR, NatalicchioA, et al.Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vasc Pharmacol, 2018; 100:1–19.
20.
JohnstonTP, KorolenkoTA, SahebkarA. P-407-induced mouse model of dose-controlled hyperlipidemia and atherosclerosis: 25 Years Later. J Cardiovasc Pharmacol, 2017; 70:339–352.
21.
KimEK, ChoiEJ. Compromised MAPK signaling in human diseases: An update. Arch Toxicol, 2015; 89:867–882.
22.
KishimotoY, KondoK, MomiyamaY. The protective role of heme oxygenase-1 in atherosclerotic diseases. Int J Mol Sci, 2019; 20:3628.
23.
KlopB, ElteJW, CabezasMC. Dyslipidemia in obesity: Mechanisms and potential targets. Nutrients, 2013; 5:1218–1240.
24.
KumarR, AkhtarF, RizviSI. Protective effect of hesperidin in Poloxamer-407 induced hyperlipidemic experimental rats. Biol Futur, 2021; 72:201–210.
25.
KyriakisJM, AvruchJ. Mammalian MAPK signal transduction pathways activated by stress and inflammation: A 10-year update. Physiol Rev, 2012; 92:689–737.
26.
LaiL, LeoneTC, KellerMP, et al.Energy metabolic reprogramming in the hypertrophied and early stage failing heart: A multisystems approach. Circ Heart Fail, 2014; 7:1022–1031.
27.
LemonsJM, FengXJ, BennettBD, et al.Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol, 2010; 8:e1000514.
28.
LiH, LiH, BaoY, et al.Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-κB pathway in rat aorta. Int J Cardiol, 2011; 152:218–224.
29.
LiY, YuY, GuoT, et al.Correlation between Nrf2/HO-1 and MAPK in oxidative stress and inflammatory response. Med Recapitulate, 2021; 27:8–13.
30.
LiuJ, AmesBN. Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease. Nutr Neurosci, 2005; 8:67–89.
31.
LiuJ, AtamnaH, KuratsuneH, et al.Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann N Y Acad Sci, 2002; 959:133–166.
32.
LiuJ, ShenW, ZhaoB, et al.Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients. Adv Drug Deliv Rev, 2009; 61:1343–1352.
33.
LiuS, HeL, YaoK. The antioxidative function of alpha-ketoglutarate and its applications. Biomed Res Int, 2018; 2018:3408467.
34.
LiuX, CaoK, LvW, et al.Punicalagin attenuates endothelial dysfunction by activating FoxO1, a pivotal regulating switch of mitochondrial biogenesis. Free Radic Biol Med, 2019a;135:251–260.
35.
LiuX, CaoK, LvW, et al.Aqueous extract of Houttuynia cordata ameliorates aortic endothelial injury during hyperlipidemia via FoxO1 and p38 MAPK pathway. J Funct Foods, 2019b;62:103510.
36.
MaldonadoE, RojasDA, UrbinaF, et al.The use of antioxidants as potential co-adjuvants to treat chronic chagas disease. Antioxidants (Basel), 2021; 10:1022.
37.
MuradF. Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med, 2006; 355:2003–2011.
38.
PunithavathiVR, Stanely Mainzen PrinceP. Protective effects of combination of quercetin and α-tocopherol on mitochondrial dysfunction and myocardial infarct size in isoproterenol-treated myocardial infarcted rats: Biochemical, transmission electron microscopic, and macroscopic enzyme mapping evidences. J Biochem Mol Toxicol, 2010; 24:303–312.
39.
RadzkiRP, BieńkoM, PierzynowskiSG. Effect of dietary alpha-ketoglutarate on blood lipid profile during hypercholesterolaemia in rats. Scand J Clin Lab Invest, 2009; 69:175–180.
40.
RenJ, PulakatL, Whaley-ConnellA, et al.Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med, 2010; 88:993–1001.
41.
RochaM, ApostolovaN, Hernandez-MijaresA, et al.Oxidative stress and endothelial dysfunction in cardiovascular disease: Mitochondria-targeted therapeutics. Curr Med Chem, 2010; 17:3827–3841.
42.
RossR, GlomsetJ, HarkerL. Response to injury and atherogenesis. Am J Pathol, 1977; 86:675–684.
43.
SmolinaN, BrutonJ, KostarevaA, et al.Assaying mitochondrial respiration as an indicator of cellular metabolism and fitness. Methods Mol Biol, 2017; 1601:79–87.
44.
SpallottaF, CencioniC, AtlanteS, et al.Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from type 2 diabetes patients: Rescue by α-Ketoglutarate and TET-TDG functional reactivation. Circ Res, 2018; 122:31–46.
45.
StreefkerkJO, De GrootAA, PfaffendorfM, et al.Influence of the nature of pre-contraction on the responses to commonly employed vasodilator agents in rat-isolated aortic rings. Fundam Clin Pharmacol, 2002; 16:485–494.
46.
SuchalathaS, SrinivasanP, DeviCS. Effect of T. chebula on mitochondrial alterations in experimental myocardial injury. Chem Biol Interact, 2007; 169:145–153.
47.
SunGY, ChenZ, JasmerKJ, et al.Quercetin attenuates inflammatory responses in BV-2 microglial cells: Role of MAPKs on the Nrf2 pathway and induction of heme oxygenase-1. PLoS One, 2015; 10:e0141509.
48.
TanY, ZhangH, GuoD, et al.Adipophilin involved in lipopolysaccharide-induced inflammation in RAW264.7 cell via extracellular signal-regulated kinase 1/2-peroxisome proliferator-activated receptor gamma pathway. DNA Cell Biol, 2017; 36:1159–1167.
49.
VargaZV, FerdinandyP, LiaudetL, et al.Drug-induced mitochondrial dysfunction and cardiotoxicity. Am J Physiol Heart Circ Physiol, 2015; 309:H1453–H1467.
50.
WangR, LiuL, LiuH, et al.Reduced NRF2 expression suppresses endothelial progenitor cell function and induces senescence during aging. Aging (Albany NY), 2019; 11:7021–7035.
51.
WarnholtzA, MollnauH, OelzeM, et al.Antioxidants and endothelial dysfunction in hyperlipidemia. Curr Hypertens Rep, 2001; 3:53–60.
52.
XuS, IlyasI, LittlePJ, et al.Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: From mechanism to pharmacotherapies. Pharmacol Rev, 2021; 73:924–967.
53.
ZhangQ, LiuJ, DuanH, et al.Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. J Adv Res, 2021; 34:43–63.
54.
ZhaoM, ZhuP, FujinoM, et al.5-Aminolevulinic acid with sodium ferrous citrate induces autophagy and protects cardiomyocytes from hypoxia-induced cellular injury through MAPK-Nrf-2-HO-1 signaling cascade. Biochem Biophys Res Commun, 2016; 479:663–669.
55.
ZhouH, HeL, XuG. et al. Mitophagy in cardiovascular disease. Clin Chim Acta, 2020; 507:210–218.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
